REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 49 filers reported holding REGULUS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $783,000 | -92.4% | 3,961,244 | -74.7% | 0.00% | -100.0% |
Q2 2018 | $10,315,000 | -7.8% | 15,647,932 | +0.3% | 0.00% | 0.0% |
Q1 2018 | $11,189,000 | -31.0% | 15,593,865 | +0.0% | 0.00% | -50.0% |
Q4 2017 | $16,217,000 | -16.7% | 15,593,272 | +0.2% | 0.00% | 0.0% |
Q3 2017 | $19,460,000 | +147.5% | 15,567,859 | +95.2% | 0.00% | +100.0% |
Q2 2017 | $7,862,000 | -40.0% | 7,977,349 | +0.5% | 0.00% | -50.0% |
Q1 2017 | $13,101,000 | -26.7% | 7,939,860 | +0.0% | 0.00% | 0.0% |
Q4 2016 | $17,862,000 | -31.7% | 7,938,495 | +0.2% | 0.00% | -33.3% |
Q3 2016 | $26,146,000 | +14.3% | 7,923,048 | +0.1% | 0.00% | 0.0% |
Q2 2016 | $22,881,000 | -58.2% | 7,917,151 | +0.1% | 0.00% | -62.5% |
Q1 2016 | $54,787,000 | -20.0% | 7,905,717 | +0.7% | 0.01% | -11.1% |
Q4 2015 | $68,464,000 | +34.4% | 7,851,397 | +0.8% | 0.01% | +28.6% |
Q3 2015 | $50,933,000 | -39.3% | 7,787,929 | +1.8% | 0.01% | -36.4% |
Q2 2015 | $83,873,000 | -34.7% | 7,652,610 | +1.0% | 0.01% | -31.2% |
Q1 2015 | $128,363,000 | +9.8% | 7,577,511 | +3.9% | 0.02% | +6.7% |
Q4 2014 | $116,941,000 | +163.1% | 7,290,574 | +12.0% | 0.02% | +150.0% |
Q3 2014 | $44,455,000 | -12.5% | 6,508,851 | +3.0% | 0.01% | -14.3% |
Q2 2014 | $50,790,000 | -10.8% | 6,317,134 | +0.0% | 0.01% | -12.5% |
Q1 2014 | $56,956,000 | +23.0% | 6,314,452 | +0.8% | 0.01% | +14.3% |
Q4 2013 | $46,310,000 | -19.9% | 6,266,598 | +2.3% | 0.01% | -22.2% |
Q3 2013 | $57,784,000 | +50.7% | 6,127,652 | +56.7% | 0.01% | +50.0% |
Q2 2013 | $38,352,000 | – | 3,909,452 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|